Cellular imaging enables the study of diseases in myriad ways, consequently impacting human health. Through visualizing individual cells, clinicians are able to diagnose diseases and scientists are able to develop drugs to treat them. There are many powerful tools to visualize cells, including fluorescence and electron microscopy. However current common imaging techniques fall short for […]

MRCK is an enzyme that has shown promise as a target for the development of new drugs to treat several aggressive cancers, including glioblastoma (GBM) and high grade serous ovarian cancer (HGSOC). BDP9066 is a highly potent and selective inhibitor of MRCK reported first in 2018. Despite excellent activity profile, BDP9066 is not a realistic […]

Xanadu’s mission is to build quantum computers that are useful and available to people everywhere. Our company was founded in 2016, and has grown to approximately 200 employees today, with headquarters in Toronto, Canada. Xanadu develops the full stack of quantum computing (QC) technology: theory, hardware, cloud service, software and applications. This project is in […]

THIS IS A GENERIC TEXT PUT IN PLACE AS THERE WAS NO PROJECT OVERVIEW